Clinical trials
Active, not recruiting Lung Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Eli Lilly and Company | 2 |
| Monopar Therapeutics | 2 |
| Novartis Pharmaceuticals | 2 |
| Royal North Shore Hospital | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Amgen | 1 |
| Boehringer Ingelheim | 1 |
| Checkpoint Therapeutics, Inc. | 1 |
| Genmab | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 22 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Neoplasms | 7 |
| Colorectal Neoplasms | 4 |
| Lung Diseases | 4 |
| Bronchial Neoplasms | 3 |
| Carcinoma, Transitional Cell | 3 |
| Colonic Neoplasms | 3 |
| Head and Neck Neoplasms | 3 |
| Neoplasms by Site | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.